DNMT3A and cardiovascular disorder: Mechanistically, DNMT3A/TET2 CHIP‐driver mutations may exert their detrimental effects on cardiovascular disease predominantly by a pro‐inflammatory activation of circulating blood cells.34, 35, 36, 37